US EditionAllergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans - PressReach
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Galderma, L’Oréal, Unilever & more to present research at IMCAS 2025
The International Master Course on Aging Science (IMCAS) World Congress 2025 will take place from 30 January – 1 February in Paris, where industry experts will share the latest scientific research and technology innovation in dermatology, cosmeceuticals, ageing science, regenerative medicine and plastic surgery.
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans - PressReach
AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ — In response to growing demand for personalized, patient-centric aesthetic solutions1,2, Allergan Aesthetics, an AbbVie Company, is proud to unveil the new AA Signature program, an innovative approach to treatment planning harnessing the power of Allergan Aesthetics’ advanced product portfolio to ad…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
